被诊断患有强迫症且对 SSRI 治疗有抵抗力的患者的临床试验
总计192个结果
-
Novartis Pharmaceuticals终止被诊断患有强迫症且对 SSRI 治疗有抵抗力的患者 | 适当剂量的 SSRI 治疗失败超过 12 周德国, 瑞士, 保加利亚, 美国, 捷克共和国
-
Eli Sprecher, MD招聘中Patients With an Implanted S-ICD Who Continue to Exercise Regularly以色列
-
Medtronic Bakken Research CenterMedtronic GmbH Germany完全的根据指南有 ICD 植入指征的患者
-
Yonsei University撤销Patients in the Treatment of Subjects With All-comer Who Are to Undergo PCI
-
Sir Mortimer B. Davis - Jewish General Hospital招聘中
-
National University Hospital, Singapore未知Focus : To Study the Differences in Patient Compliance to Immunosuppressive Treatments and Patient Preference.新加坡
-
University of PennsylvaniaLeonard Davis Institute完全的
-
Rambam Health Care Campus未知Patients Diagnosed With Severe Mental Illness以色列
-
Karabuk UniversityBolu Izzet Baysal Physiotherapy and Rehabilitation Training and Research Hospital完全的
-
Nantes University HospitalFrench Intergroup of Myeloproliferative syndromes招聘中
-
Greater Baltimore Medical Center撤销
-
Peking University未知Patients With Digestive System Tumors Resistant to PD-1 Inhibitors
-
Instituto do Cancer do Estado de São Paulo未知
-
AstraZeneca完全的The Aim of This Study is to Investigate the Frequency and Related Risk Factors of Recurrence, and Quality of Life in Patients With GERD After Treatment With PPI大韩民国
-
Sohag UniversitySuez Canal University完全的Patients With Axial SpA According to ASAS Criteria | Patients With Unilateral or Bilater Hip Damage According to BASRI Score | Age > 18埃及
-
China Medical University HospitalAcademia Sinica, Taiwan未知Genomic Aberrations in Patients Diagnosed as Congenital Malformation With Unknown Etiology台湾
-
University Health Network, TorontoThe Kidney Foundation of Canada; Canadian Urologic Oncology Group完全的
-
Chittagong Medical College完全的To See the Safety and Efficacy of the Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma Patients孟加拉国
-
SK Chemicals Co., Ltd.Toray Industries, Inc完全的
-
Gruppo Italiano Malattie EMatologiche dell'Adulto完全的在不超过两个先前治疗线后初始反应（CR、PR ≥ 6 个月）后复发的 CLL 患者；或者 | CLL 难治性患者（SD、PD 或 CR/PR < 6 个月）遵循不超过两个先前治疗线意大利
-
Latin American Cooperative Oncology GroupGlaxoSmithKline完全的管理系统1 | 开始研究的绩效状态为零到二 | 接受最多一次化疗的患者 | 紫杉烷类药物后进展的患者阿根廷, 巴西, 秘鲁
-
Philogen S.p.A.终止Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical Resection意大利, 德国
-
Shanghai General Hospital, Shanghai Jiao Tong University...尚未招聘评估 nAMD 患者玻璃体内注射 LX109 的安全性和耐受性
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)完全的
-
CABYCBayer; Genzyme, a Sanofi Company; Fundacion Clinic per a la Recerca Biomédica; Grupo Español de... 和其他合作者撤销
-
Centre Hospitalier Universitaire Dijon完全的
-
Hartford Hospital未知
-
University Hospital, Basel, Switzerland撤销
-
Notal Vision Ltd.完全的
-
General Hospital Groeninge完全的
-
Taipei Veterans General Hospital, Taiwan招聘中
-
The Hospital for Sick ChildrenUniversity of Calgary完全的
-
Yanbing Li尚未招聘西格列他钠治疗T2DM患者的疗效和安全性 | 二甲双胍联合甘精胰岛素治疗降糖效果仍不佳的2型糖尿病患者 | 128 名患者按 1:1 随机分配 | 二甲双胍甘精胰岛素联合西格列他钠片48mg/日组 | 二甲双胍和甘精胰岛素联合安慰剂组 | 调查员开始审判 | 治疗 18 周时 HbA1C 相对于基线的变化中国
-
International Centre for Diarrhoeal Disease Research...Unilever Nederland Holdings完全的
-
Nan ShenNovartis尚未招聘表征狼疮性肾炎 (LN) 患者的分子特征，以了解患者对 Soc 反应的机制 | LN 患者分子谱和临床注释的综合分析，以了解 LN 疾病内型的异质性 | 验证表 3-1 中提出的候选生物标志物组与 LN 疾病监测的关联